Lisa Boyette, MD, PhD, was named a 2016 PharmaVOICE 100 honoree. The PharmaVOICE 100 is an annual list of inspirational and innovative individuals recognized for their positive contributions to the life-sciences industry. Boyette is the co-founder and CEO of Curable, a non-profit research accelerator that applies engineering approaches to medicine to develop solutions for rare diseases.

“I am proud to join such distinguished colleagues in the 2016 PharmaVOICE 100,” said Boyette. “We founded Curable in 2014 to accelerate medical research and develop a cure for primary sclerosing cholangitis (PSC) in time to save the life of my brother Jon and other patients with this disease. Thanks to our team’s dedication and determination, we are making great strides toward our goal of getting new therapeutic options and an early diagnostic for PSC in Phase II clinical trials in five years.”

Boyette was also named to Pittsburgh Magazine‘s 40 Under 40 list for 2016.